In the article listed above, the serum FGF21 data presented in Supplementary Table 1 in the "lean (291.8 ng/L [144.5–512.0])” and "overweight/obese (208.7 ng/L [94.4–325.7])" columns were inversed due to a mistake in typing. It should have been presented as “lean (208.7 ng/L [94.4–325.7])” and “overweight/obese (291.8 ng/L [144.5–512.0]).” The authors apologize for this error. The online version of the Supplementary Data for this article (https://doi.org/10.2337/ db07-1476) has been updated to correct this error.
CITATION STYLE
Zhang, X., Yeung, D. C. Y., Karpisek, M., Stejskal, D., Zhou, Z. G., Liu, F., … Xu, A. (2019, January 1). Erratum: Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans (Diabetes (2008) 57 (1246–1253) DOI: 10.2337/db07-1476). Diabetes. American Diabetes Association Inc. https://doi.org/10.2337/db19-er01c
Mendeley helps you to discover research relevant for your work.